| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.26▲ | 7.26▲ | 7.26▲ | 7.37▼ | 5.29▲ |
| MA10 | 7.27▲ | 7.28▼ | 7.29▼ | 7.99▼ | 3.05▲ |
| MA20 | 7.70▼ | 7.78▼ | 7.93▼ | 7.26▼ | 1.99▲ |
| MA50 | 8.47▼ | 9.69▼ | 8.47▼ | 3.40▲ | 2.44▲ |
| MA100 | 10.31▼ | 6.04▲ | 4.63▲ | 2.18▲ | N/A |
| MA200 | 5.57▲ | 3.44▲ | 2.77▲ | 2.14▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.017▲ | 0.000▲ | -0.102▼ | -0.412▼ | 0.976▲ |
| RSI | 31.044▼ | 37.152▼ | 40.874▼ | 54.959▲ | 69.084▲ |
| STOCH | 13.636▼ | 11.018▼ | 9.167▼ | 6.442▼ | 34.362 |
| WILL %R | -96.825▼ | -96.825▼ | -97.004▼ | -99.018▼ | -69.665 |
| CCI | -43.056 | -46.378 | -50.443 | -71.911 | 108.015▲ |
|
Tuesday, August 12, 2025 05:05 AM
Continued advancement of SIL204 preclinical program with strong efficacy data across multiple KRAS-driven cancer types; company strengthened financial position and maintains progress toward clinical t ...
|
|
Friday, August 01, 2025 05:54 AM
As part of the deal, Silexion will issue new unregistered warrants to purchase up to 304,212 of the company’s ordinary shares. These new warrants will have an exercise price of $11.32 per share and a ...
|
|
Thursday, July 31, 2025 05:00 PM
H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 7.39 | 7.42 | 7.16 | 7.24 | 10,900 |
| 14/08/25 | 7.20 | 7.529 | 7.20 | 7.36 | 14,200 |
| 13/08/25 | 7.42 | 7.42 | 7.16 | 7.40 | 38,100 |
| 12/08/25 | 7.79 | 7.79 | 7.1105 | 7.25 | 39,739 |
| 11/08/25 | 8.29 | 8.29 | 7.20 | 7.60 | 54,100 |
| 08/08/25 | 8.59 | 8.59 | 8.20 | 8.23 | 17,900 |
| 07/08/25 | 8.44 | 8.60 | 7.09 | 8.58 | 29,700 |
| 06/08/25 | 8.895 | 8.98 | 8.25 | 8.311 | 36,255 |
| 05/08/25 | 9.00 | 9.045 | 8.77 | 8.86 | 34,700 |
| 04/08/25 | 9.46 | 9.46 | 8.60 | 9.04 | 95,200 |
|
|
||||
|
|
||||
|
|